Canaccord Genuity Reiterates Buy Rating on Pulmonx Corp. (LUNG)
Tweet Send to a Friend
Canaccord Genuity analyst John Young reiterated a Buy rating and $16.00 price target on Pulmonx Corp. (NASDAQ: LUNG).The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
